EmPatient

What EmPatient does

EmPatient is a French private limited company (SARL), founded in 2009 and headquartered in Rueil-Malmaison, France, that delivers therapeutic patient education (ETP) training and consulting services to healthcare professionals, patient associations, public health institutions, and pharmaceutical companies. The company's offering is organized around five service lines: patient surveys and insights, patient information/learning/engagement, training programs in accompaniment and ETP, co-construction with patient associations, and public health evaluation. Revenue is split 60/40 between training and consulting, with disclosed pricing of €700 per participant for the patient-intervenant training program and larger institutional engagements with named clients including MSD France, Roche, Sandoz, UCB, Abbvie, Haute Autorité de Santé (HAS), and France Assos Santé.

The core technology layer is modest: a proprietary e-learning module library covering ETP theory and active listening, supplemented by a live "Classes Virtuelles" (virtual classroom) capability launched in November 2020 in response to the COVID-19 pandemic. Condition-specific branded programs such as PEAU CIBLE® (onco-dermatology) extend the content library. The business is gated by two regulated credentials — Qualiopi certification from APAVE (initial 2021, renewed 2024) and registration with ANDPC (Agence Nationale du Développement Professionnel Continu) — which together control access to publicly funded training in France. Delivery is sales-led and community-led: distribution runs through direct outreach, patient-association networks, healthcare conferences, and a channel partnership with Institut Supérieur de l'Alimentation (ISA). Operational scale signals include 63 training plans and 855 participants in 2016, a 9.4/10 commissioning-client satisfaction rating, and 50+ cumulative partners across patient associations, medico-social structures, healthcare facilities, pharmaceutical companies, and public authorities. The company has no disclosed external funding, employs a small team (5 per firmographics, ~15 per anniversary communications), and operates primarily in France with limited European extension via GAMIAN-Europe and Servier joint brochure work.

Name

EmPatient

Legal name

EmPatient

Website

https://empatient.fr

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Short description

EmPatient is a French, Rueil-Malmaison-based SARL founded in 2009 that delivers Qualiopi-certified therapeutic patient education (ETP) training and consulting to healthcare professionals, patient associations, public health agencies, and pharmaceutical companies across France.

Ownership category

akta.pro rank

Product category

Healthcare Training and Consulting

SIC

Services-Health Services (8000), Services-Educational Services (8200)

akta.pro primary industry

Medical Assisting (Clinical & Administrative) (EDAOAJAA)

Keywords

• Therapeutic patient education
• Healthcare professional training
• Patient insights research
• Public health evaluation
• Patient association services

Headquarters

HQ city

Rueil-Malmaison

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Training Services: Training programs in therapeutic patient education for healthcare professionals and patient association members. Includes basic ETP training (40h), advanced training, coordination training, active listening skills, and patient-intervenant training. Revenue split: 60% of total business.
2. Consulting Services: Consulting services including patient surveys and insights, public health evaluation, co-construction with patient associations, and strategic support. Revenue split: 40% of total business.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels4 records

Core offering

EmPatient is a French health-services firm that delivers therapeutic patient education (ETP) through certified training programs for healthcare professionals and patient associations, alongside consulting, patient surveys, co-construction partnerships, and public health evaluation services. The firm monetizes approximately 60% of revenue through training delivery (including the Patient-Intervenant 40-hour program and PEAU CIBLE® for skin cancer) and 40% through consulting engagements, supported by Qualiopi certification and ANDPC registration.

Product overview

EmPatient is a patient-centered health solutions company offering a portfolio of five integrated service lines focused on therapeutic patient education and patient empowerment. The core offerings include: (1) Patient Surveys & Insights for researching patient realities; (2) Patient Information, Learning & Engagement to help patients become active healthcare participants; (3) Training programs in patient accompaniment and therapeutic patient education (ETP) for healthcare professionals and associative actors; (4) Co-construction and associative partnership services; and (5) Public health evaluation. Additional specialized programs include PEAU CIBLE® for skin cancer patient education, e-learning modules for remote therapeutic education training, and virtual classroom delivery of training content. The company operates primarily as a service and training organization rather than a software platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient Surveys & Insights (Enquêtes & Insights patients) Survey and insights research service that gathers and analyzes patient perspectives, delivered to patient associations, healthcare institutions, and pharmaceutical companies in France.
• Patient Information, Learning & Engagement Service line that develops and delivers patient information, learning content, and engagement programs for patient associations, healthcare institutions, and pharmaceutical partners.
• Training in Patient Accompaniment & Therapeutic Education Qualiopi-certified training program (including the 40-hour Patient-Intervenant program) that prepares healthcare professionals and patient intervenants to deliver therapeutic patient education (ETP) in France. ANDPC-registered for public funding eligibility.
• Co-construction & Associative Partnerships Consulting service that supports co-construction of patient programs and associative partnerships, embedding patients as partners in design and delivery for patient associations and pharmaceutical sponsors.
• Public Health Evaluation Evaluation service for public health programs, commissioned by healthcare institutions and French public health authorities, covering ETP program impact and patient-outcome measurement.
• PEAU CIBLE® Skin Cancer Patient Education Program Dedicated skin-cancer-focused therapeutic patient education program within EmPatient's training portfolio, targeted at patient associations and healthcare professionals working in onco-dermatology.
• Virtual Classes (Classes Virtuelles) Interactive remote training offering launched in November 2020 that delivers EmPatient's therapeutic patient education programs virtually, enabling distance participation while preserving interactivity for healthcare professionals and patient intervenants.

Quantifiable outcome

• 9.4/10 client satisfaction rating for training programs
• +2 more outcomes

Named customers11 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

15 partnerships are on record, tiered core, major and minor.

• SOS HépatitescoreStrategic or Co-development PartnerPartnership for coordination of Hepatitis B General States (Etats Généraux de l'Hépatite B), including patient surveys, regional round tables, and policy recommendations development.
• France Greffe Cœur PoumonscoreStrategic or Co-development PartnerPartnership for transplant patient education including Super Witness Transplant training, SuPAIR training programs, and guide development for newly transplanted patients.
• Haute Autorité de Santé (HAS)majorStrategic or Co-development PartnerCommissioned for testing and qualitative evaluation of informational documents on neonatal screening, conducting focus groups at Parisian hospitals.
• France Assos SantémajorStrategic or Co-development PartnerStrategic orientation development support for the national union of patient associations, including regional meetings and workshops.
• AFLAR (Alliance Nationale Contre l'Ostéoporose)coreStrategic or Co-development PartnerPartnership for organization and animation of osteoarthritis general states, including citizen panels, national surveys, and regional round tables.
• FIMATHO (Filière Santé Maladies Rares)coreStrategic or Co-development PartnerPartnership for Parent-Intervenant training in therapeutic patient education for parents of children with rare diseases, involving multiple rare disease filieres.
• RENALOOminorStrategic or Co-development PartnerPartnership for training volunteers of the kidney disease patient association, including 2-day initial training on association knowledge, active listening, and advocacy.
• KLS-FranceminorStrategic or Co-development PartnerPartnership for facilitation of exchange day for Kleine-Levin syndrome patients and families, supporting the rare neurological condition association.
• Les Petits BonheursminorStrategic or Co-development PartnerPartnership for evaluation of associative project for HIV patients celebrating 15 years, assessing project effects and organizational changes.
• MSD FrancecoreStrategic or Co-development PartnerLongstanding partnership for annual national training days on inflammatory diseases (MICI, RIC) in immunology, including program development and expert coordination.
• #ApresJ20 Covid Long FranceminorStrategic or Co-development PartnerPartnership for training volunteers to facilitate remote discussion groups for long COVID patients, addressing pandemic-related patient support needs.
• ISA - Institut Supérieur de l'AlimentationminorChannel Partner/ Reseller/ DistributorPartnership for distribution of therapeutic patient education training programs through ISA's continuing education catalog.
• Various Pharmaceutical Companies (MSD, Roche, Sandoz, UCB, Abbvie)coreStrategic or Co-development PartnerPartnership with pharmaceutical companies for public health evaluations and training programs in therapeutic patient education.
• GAMIAN-EuropeminorStrategic or Co-development PartnerEuropean partnership for co-construction of depression management brochures with patient representatives from multiple European countries.
• ServierminorStrategic or Co-development PartnerPartnership for co-construction of patient information brochures on depression and anxiety management, involving European patient associations.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Parexel: Global clinical research organization with patient engagement and patient experience services for biopharma. Comparable as a broad incumbent whose patient-focused services compete for the same pharma programs, though delivered through a much larger global infrastructure.
• IQVIA: Global life sciences services and technology company with patient engagement, real-world evidence, and HCP education offerings. Comparable as a broad incumbent competing for the same pharma patient-engagement budgets, though at a much larger scale than EmPatient.

Direct peers

• Wefight: French health-tech company building patient companion apps that deliver therapeutic education and engagement. Comparable as a France-based company focused on patient education and patient empowerment, though more product-led than EmPatient's services model.
• Carenity: French patient community platform generating real-world patient insights for pharma and researchers. Comparable because its patient insight generation and patient-centric research directly overlaps with EmPatient's patient surveys and consulting services.
• Kap Code: French company specializing in patient insights through social listening and patient community analytics (Publicis subsidiary). Comparable because its patient surveys and patient-realities research overlap directly with EmPatient's 'Enquêtes & Insights patients' service line.
• Calmedica: French patient support programs provider offering therapeutic education, adherence, and patient engagement services for pharma clients. Comparable due to similar therapeutic patient education focus and pharma-sponsored program delivery model.
• Observia: French health-tech firm providing patient engagement, education, and adherence solutions to pharmaceutical companies. Comparable because it serves the same pharma customer base with patient-support programs that compete for the same budget lines.
• Sanoïa: French patient engagement and eCOA/ePRO platform supporting patient-reported outcomes in real-world studies. Comparable as a France-based company bridging pharma, patient associations, and patient data — adjacent to EmPatient's patient surveys and co-construction work.
• Bepatient: French digital health company offering patient engagement and education platforms serving pharmaceutical companies and patient communities. Directly comparable as a France-based patient-centric solutions provider competing for similar pharma and association budgets.

Emerging players

• Ad Scientiam: French digital health company developing patient self-monitoring solutions for chronic diseases, including therapeutic education modules. Comparable as a Paris-based emerging player in patient-centric chronic disease programs that overlaps EmPatient's therapeutic education focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/empatient-empowering-patient-

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EmPatient